Essa Pharma Inc Reports Results For The Quarter Ended In June: Earnings Summary

ESSA Pharma

16/08/2021 13:01

* ESSA Pharma Inc  EPIX.OQ  reported a quarterly adjusted loss
of 21 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 26 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* ESSA Pharma Inc's reported EPS for the quarter was a loss
of 21 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* ESSA Pharma Inc shares had fallen by 58.3% this quarter and
lost 0.1% so far this year.
* The company reported a quarterly loss of $8.75 million.
* Wall Street's median 12-month price target for ESSA Pharma Inc
is $42.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 12:01 p.m.  ​All
figures in US dollars unless otherwise stated